Escherichia coli heat stable enterotoxin (ST.) caused Cl-secretion across T84 cell monolayers in a dose-dependent manner only when applied to the apical membrane surface and not when applied to the basolateral surface. Measurement of cAMP, cGMP, and free cytosolic Ca2l in response to STa suggested that cGMP alone mediated the Cl-secretory response. Studies utilizing blockers of the Na+,K+-ATPase pump, a Na+,K+,ClI cotransport system, a K+ channel, and a Cl-channel suggest that all of them participate in the Clsecretory process induced by ST.. The results suggest that the Cl-secretory response induced by STa is mediated by cGMP after the enterotoxin binds to its receptor on the apical membrane. The enterotoxin, by increasing cGMP, opens a K+ channel on the basolateral membrane as well as a Cl-channel on the apical membrane. The activation of these ion exit mechanisms, together with activations of the Na+,K+,Cl-cotransporter and the Na+,K+-ATPase pump drives Cl-exit through the Cl-channel on the apical membrane.
Introduction
Escherichia coli heat stable enterotoxin (STa)' causes intestinal secretion of fluid and electrolytes and an increase in cellular cGMP levels (1, 2) . Studies by other investigators suggest that cGMP is the secondary messenger mediating the secretory response induced by the enterotoxin (3) (4) (5) (6) . The mechanism of action beyond the step of cGMP formation, including the transport pathways involved in the secretory process, has not been fully elucidated. Evidence in the literature suggests that cGMP inhibits a "neutral" Na+,Cl-absorptive process, and stimulates an "electrogenic" Cl-secretory mechanism (4) (5) (6) . Our laboratory has utilized a cultured human colonic epithe-(P.D.) resulted from active transport of ions; the I,,, maintained the P.D. at zero. In our experimental system, P.D. across T84 cell monolayers have been shown to result from the transepithelial secretion of chloride ions since they are the only ions transported transcellularly by T84 cells. Cl-ions carry negative charges with them. Hence, the amount of Cl-secreted can be easily quantitated by recording the electrical current (I4) needed to nullify the electrical charges carried by Cl-ions from one reservoir to another. For practical purposes readers can equate I4, with Cl-secretion in this series of studies. Results in Table I support our conclusion in this regard.
Radionuclide efflux and uptake studies. Bumetanide-sensitive and insensitive 86Rb+ efflux, bumetanide-sensitive 86Rb+ uptake and 'Cluptake were studied to determine the effect of STa on specific ion transport pathways. Radionuclide uptake or efflux was assayed using replicate confluent monolayer cultures of T84 cells attached to 35 mm culture dishes.
Bumetanide-sensitive and insensitive 86Rb+ efflux was assayed in the presence of 0.5 mM ouabain as described previously ( 15) to determine whether the K+ channels and/or the Na+,K+,ClP cotransporter were activated. Confluent monolayer cultures of T84 cells were loaded to steady state with 86Rb+ by incubation for 4 h in buffer containing 138 mM NaCl, 10 mM Hepes-Tris, pH 7.4, 10 mM glucose, 2 mM RbC1, 1 mM MgCl2, and 0.25 ACi/ml 86Rb+. The monolayers were washed and incubated with buffer containing 140 mM choline chloride, 10 mM Hepes-Tris, pH 7.4, 1 mM MgCl2, and 0.5 mM ouabain for 1 h. Effluxes were initiated by aspirating this buffer and adding buffer containing 140 mM NaCl, 10 mM Hepes-Tris (pH 7.4), 1 mM MgCl2, and 0.5 mM ouabain with or without 0.1 mM bumetanide and with or without STa or VIP. Effluxes were stopped after 15 and 30 min by washing rapidly four times with ice-cold 100 mM MgC12 10 mM Hepes-Tris, pH 7.4.
Bumetanide-sensitive 86Rb+ uptakes were determined in the presence of ouabain as described previously (9) to assess whether the Na+,K+,Cl-cotransport pathway is directly activated by STa. The cells were first incubated in KCl buffer for 1 h followed by incubation in isotonic sucrose buffer (241 mM sucrose, 10 mM Hepes-Tris, 1 mM MgCl2) containing 0.5 mM ouabain for 1.0 h. This double preincubation procedure eliminated Na+,K+ ATPase activity as well as removing all extracellular ions while maintaining relatively high cellular K+ concentrations (9, 16) . 86Rb+ uptakes were determined after prestimulating the cells with STa in sucrose buffer by aspirating the preincubation buffer and replacing it with uptake buffer (135 mM NaCl, 10 mM Hepes-Tris, pH 7.4, 5 mM KC1, 1 mM MgCl2) containing 2 MCi/ml 86Rb+ with or without 0.1 mM bumetanide. The initial rate of 86Rb+ uptake under these conditions is largely (> 95%) bumetanide sensitive and Na+ and Cl-dependent (9) . Both 86Rb+ and 3Cl-uptakes were terminated using the MgSO4/sucrose wash procedure described previously (9, 11, 15, 16) .
The initial rate of 3C1 uptake mediated by the Cl-channel was estimated using a modification of the method originally reported to test whether the Cl-channel is opened directly by STa (16) . An example of the method is shown in Fig. 1 . Replicate, confluent monolayers of Tg4 cells were preincubated in KCl buffer (140 mM KCI, 10 mM Hepes-Tris, pH 7.4, 1 mM MgCI2). After 1 h intracellular K+ and Clconcentrations approached 140 and 100 mM, respectively (16) . The cells were stimulated with either STa or VIP by preincubating for the stated times in KCI buffers containing given concentrations of these effectors. 36C1-uptake was assayed by aspirating this preincubation buffer and replacing it with K gluconate buffer (140 mM K gluconate, 10 mM Hepes-Tris, pH 7.5, 1 mM Mg gluconate) containing 1 ,Ci/ml 36CI-(1.2 mM final 36CI-). Under these conditions a transient Cldiffusion potential is created that favors uptake of 36CL-through an electrogenic (i.e., channel) mediated mechanism (19 (20, 21) with some modifications. T84 monolayers were plated and grown as described previously. Monolayers were rinsed free of culture media and then incubated for 15 min at room temperature in calcium-free Ringer's solution, buffered with 30 mM Hepes containing 1.0 tM Fura-2/AM. 5 vol of identical Ringer's buffer containing calcium and Fura-2/AM (1.2 mM and 1.0 ,M, respectively) were then added, and the incubation continued for an additional 75 min at 37°C. After the loading incubation, the entire ring assembly was incubated for 15 min at 37°C in the buffer used for fluorescence measurements. This buffer contained: NaCl 137.0 mM, KCI 5.4 mM, CaCl2 1.0 mM, KH2PO4 0.4 mM, MgCl2 0.5 mM, MgSO4 0.4 mM, NaHCO3 4.2 mM, Na2HPO4 0.3 mM, Hepes 10.0 mM, and glucose 0.6 mM, with the pH adjusted to 7.4 with NaOH. The final incubation step served to remove any dye remaining outside the cell or in contact with the cell membrane.
Fluorescence measurements were carried out in a fluorescence spectrophotometer (model 650-1OS; Perkin-Elmer, Norwalk, CT). Excitation monochromator settings were 340 and 380 nm with a slit width of 5 nm. Emitted light was collected through a 495-515-nm interference filter with an emission slit of 10 nm. Monolayers were mounted for measurement as follows: the Nuclepore filter holding the monolayer was peeled offthe Lexan ring and attached to a polystyrene support, which was then placed in a standard 10-mm cuvette. The polystyrene support, with the attached monolayer, was exposed to the same buffer in the cuvette on both the apical and basolateral sides. Orientation of the monolayer within the cuvette itself was 450 to the excitation beam and angled 10-20°from the vertical plane to minimize the interference from reflected excitation light. Excitation monochromator settings were changed manually every 10 s with the wavelength drive control.
Free cytosolic calcium levels were calculated from the equation Thus it is unclear whether its ability to inhibit the I. induced by ST0
was attributable to its effect on the Cl-channel or its effect on cGMP.
carried out as reported previously (8) over the same time frame as for Na' and Cl-fluxes. There was no significant changes of mannitol flux after the addition of ST0: J;a:s,,to0 and Js -mnto were 0.002±0.001, 0.003±0.001 gmol/h * cm2, respectively, in period I-II (prior to the addition of 2.5 X 10'-M ST.) and 0.003±0.002, 0.003±0.003 1umol/h cm2 in period III (after the addition of ST0, n = 3 pairs). Another question that arose was whether the increase in monolayer's conductance was reversible. When ST0 antibodies were used to reserve ST0's action in another study (26), monolayers conductance was also reversed to control level in 30 min (ST0 antibodies reversed 97±3% of ST.-induced increase in I., and 93±7% of ST0-induced increase on conductance in that study, n = 3). In another experiment the bathing media were replaced with ST0-free media after ST0 had induced an increase in IC and conductance. 30 min after washing 88±7% of ST0- conductance were reversed (n = 7). Repeat washing tended to increase monolayer's conductance and might cause a lesser degree of reversal in conductance. Inhibition ofSTa-stimulated Ct secretion by specific inhibitors ofmembrane transport. We have previously shown that a loop diuretic, bumetanide, inhibits the basolaterally localized Na',K+,Cl-cotransport system in the T84 cell line (9) . This transport pathway serves as the Cl-uptake pathway and its inhibition by bumetanide results in a reversal or inhibition of Cl-secretion mediated by cAMP or Ca2+ (9, 11, 13). Therefore, bumetanide was used to test the involvement of this cotransport pathway in the Cl-secretory process activated by STa.
Serosal addition of 10-4 M bumetanide inhibited the action of ST8 while mucosal addition has little or no effect. As was the case for VIP-and PGEI-induced Cl-secretion, bumetanide incompletely inhibited the action of STa. At 10-4 M bumetanide, added 20 min before addition of STa, -20% of the peak I,, induced by STa persisted (Fig. 2) . In the presence of bumetanide, the time course of the response to STa showed that the late effect of ST,, rather than the initial effect, was inhibited. Thus the time course of the response was shorter in duration, reaching a peak within 10 min. Unidirectional Na+ and Cl-fluxes in the presence of bumetanide are summarized in Table I , group III. 10-4 M bumetanide significantly reduced the STa-induced increases in serosal to mucosal as well as mucosal to serosal Cl-flux resulting in reduced net Cl-secretion with a corresponding decrease in ISC. Bumetanide, by itself, had no effect on the basal Na' or Cl-fluxes (group III, period II). Bumetanide also reversed the action of STa when added after STa had elicited a response (data not shown).
Barium, a K+ channel blocker, has been found to inhibit Cl-secretion in a number of epithelia (10, 27, 28) . In T84 cells, barium inhibits a K+ recycling mechanism on the basolateral membrane. A K+ exit mechanism is intimately involved in the Cl-secretory process mediated by cAMP or Ca2" and appears to serve as a site regulated by a number of secretagogues (10, 11, 13, 15) . Therefore, barium was used to test whether Clsecretion induced by ST. required the same K+ recycling mechanism. We found that BaCl2 added serosally inhibited the increase in IC induced by STa, while mucosal addition had little or no effect. At a concentration of 3 mM, 80% of the effect of ST8 was inhibited (Fig. 2) . The results of unidirectional and net Na+ and Cl-fluxes, summarized in Table I , group IV, confirm that barium inhibited net Cl-secretion. Similar to bumetanide, barium by itself had no effect on basal I, or on unidirectional Na+ and Cl-fluxes (see group IV, period II). In contrast to bumetanide, barium had little effect on the increase in mucosal to serosal Cl-movements induced by ST.. Unidirectional Cl-fluxes in both directions were increased by STa regardless of the presence of barium, while net Cl-flux was reduced to near zero. The inhibitory effect of barium on the action of ST8 was reversible. Barium also reversed the action of ST8 when added after ST8 had elicited a response (data not shown). Other putative K+ channel blockers including apamin (10-6 M), tetraethylammonium chloride (10-2 M), and 4-aminopyridine (10-2 M) did not exhibit an inhibitory effect. Quinidine (3 X 10-4 M) caused a rise in IC before exerting an inhibitory action. The results are similar to those observed with secretagogues such as VIP or PGEI, which increase cellular cAMP levels.
Ouabain, a Na+,K+-ATPase inhibitor, also inhibited and reversed ST8-induced ISC when added to the serosal reservoir at a concentration of 10-4 M. When ouabain was added after ST8
had elicited a response, -80% inhibition was observed 20-25 min after the addition of ouabain and 85 to 90% inhibition at 45 min. Similar results were obtained with ouabain pretreatment (data not shown).
5-Nitro-2-(2-phenylpropylamino)-benzoic acid, an anthracene derivative, is a recently developed potent blocker of the Cl-channel. This Cl-channel blocker, which was tested initially in the thick ascending limb of the loop of Henle (29) (Fig. 2) . This putative Cl-channel blocker also reversed the I,, induced by ST8 when added after ST. had elicited a response (data not shown). Unfortunately, at the concentration of the agent used in this study, 10-4 M, the compound partially inhibited the rise in cellular cAMP induced by VIP and the rise in cellular cGMP induced by STa (unpublished observations) and caused the results to be inconclusive. Any conclusion related to 5-nitro-2-(2-phenylamino)-benzoic acid's effect in blocking C1-secretion must remain inconclusive as long as it is unknown as to what extent the inhibition is due to an effect on the Cl-channels or due to an effect on cGMP.
Evidence for STa-induced K+ efflux on the basolateral membrane, and its similarity to a cAMP-induced effect. To verify the existence of a K+ efflux pathway and to test if barium inhibited this process, monolayers were preloaded with 86Rb+ (as a tracer for K+) and mounted in the Ussing chamber. This method allows the measurement of 86Rb+ efflux across both the apical and basolateral surfaces while Cl-secretion, as reflected by the I, is simultaneously monitored (10, 11, 13) . The apparent first order rate constants, along with the mean IS and conductance of the monolayers for each time interval in which additions were made, are shown in Table II . In the basal state, the rate of 86Rb+ efflux into the mucosal bath was 10 to 20-fold less than that into the serosal bath. The addition of ST8 increased the rate of 86Rb+ efflux into the serosal bath by approximately two-fold, while the amount of 86Rb+ efflux into the mucosal bath remained small. The increase in basolateral membrane 86Rb+ effilux rate was totally inhibited by the prior addition of 3 mM barium to the serosal bathing medium. 3 mM barium had no effect on 86Rb+ efflux in the basal state. Net Cl-secretion induced by ST., as indicated by the IS was also inhibited by barium. The graded dose effect for the inhibition of STa-induced I,, by barium is shown in Fig.   4 . This effect is identical to that seen with barium inhibition of VIP-or PGE1-induced I,, (10, 11) , but differs from the inhibitory action of barium on A23187-or carbachol-induced I,.
The I,, response of A23 187 is more resistant to barium inhibition, while the I,, response of carbachol is totally unaffected to barium (10, 13) . It should be noted that at concentrations of 3 mM or above, barium precipitated in the solution and therefore the effective concentration was lower than indicated.
We then quantitated the magnitude of 86Rb+ efflux induced by a combination of STa and carbachol as well as by ST8 and VIP (Table III ). An additive effect between ST8 and either VIP or carbachol would confirm that the compounds act via different pathways while the lack of an additive effect would suggest that they act via the same pathway. 86Rb+ efflux induced by the combination of ST8 and carbachol was additive, while 86Rb+ efflux induced by the combination of ST. and VIP was not different from 86Rb+ efflux induced by ST. or VIP alone (Table III) . These findings suggest the presence of two different types of K+ efflux pathways, one activated by ST. or VIP, and the other activated by carbachol. The former is sensitive to barium as described above and previously (10) , while the latter is less so (13) . In addition, the increase in I,, induced by the combination of STa and carbachol was greater than the predicted additive response (potentiated), while the increase in I induced by ST8 and VIP was less than additive and approximated that induced by VIP alone (Table III) . At a concentration of VIP (10-8 M) that gave a maximal response, 10-6 M ST. caused no further increase in ISC. Likewise, 10-8 M VIP added to 10-6 M ST8-pretreated monolayers brought the peak I4, from 15 .0±1.0 gA/cm2 to 26.5±2.5 tzA/cm2, an I,, level (11) or VIP and A23187 (12) .
A complimentary study was carried out with 86Rb+-preloaded monolayers grown on culture dishes as described previously (15) . In these studies, 86Rb+ efflux was quantitated in the presence of ouabain with or without bumetanide. The study allowed us to determine if the increase in 86Rb+ efflux is dependent on the Na',K+,Cl-cotransport mechanism and the Na',K+-ATPase pump. The findings are summarized in Fig. 5 .
Similar increases in 86Rb+ efflux were observed with 2.5 X IO-' M STa in the presence of ouabain alone or in the presence of ouabain and bumetanide. The other words, the bumetanide sensitive effluxes, which represent effluxes of 86Rb+ via the Na',K+,Cl-cotransport carrier, were not affected by ST5.
Therefore, the increase in 86Rb+ efflux induced by STa must have occurred via another transport pathway, most likely that K+ channel. Taken together, our results suggest that STa activates a K+ transport pathway which is sensitive to cAMP, but not the one which is sensitive to Ca2+. The results also suggest that the opening of the K+ transport pathway is an effect of STa independent of the Na+,K+,Cl-cotransport pathway and the Na+,K+-ATPase pump. Uptake studies. Uptake studies were carried out for two purposes. First, 36C1-uptakes were performed to test whether the Cl-channel is opened by the STa and if so, how the magnitude of this effect compared with that produced by VIP. Second, 86Rb+ uptakes were assayed, in the presence of ouabain with or without bumetanide, to reassess whether the Na+,K+,Cl-cotransporter pathway is directly activated by STa.
For the first purpose, initial rates of 36C1-uptakes were determined under conditions that favor the uptake of 36C1-through Cl-channel mediated processes. Dose-dependent activation of the apical-localized Cl-channel by VIP can readily be detected using this method. Similarly, application of ST. determinations. Under these conditions, 0.25 MM STa had no effect on bumetanide sensitive 8tRb efflux, but increased the rate of bumetanide-insensitive 86Rb efflux almost twofold. This increase was similar to, but slightly less than that observed with 10 nM VIP under identical conditions (data not shown).
activated the Cl-channel in a dose-dependent manner. The dose-response curve was nearly identical to that observed for ST.'s effect on I5C (data not shown). However, even at saturating doses (1 ,M), ST, required at least 30 min to achieve 90% maximal stimulation ofthe Cl-channel (Fig. 6 ). This contrasts with the action of VIP which gives 90% maximal stimulation within 5 min. Thus, the action of STa is slower than that observed with VIP, agreeing with the rather sluggish response to STa in the Ussing chamber. Furthermore, even at supramaximal doses of STa (1 MM) and optimal stimulation times (30-60 min), the extent of Cl-channel activation by STa was only 73±4% that observed with saturating doses of VIP. These data are similar to the peak I,, values produced by STa and VIP in the Ussing chamber. To address the second purpose, 86Rb+ uptakes were carried out in the presence or absence of prior stimulation by 1 uM STa under conditions designed to optimize 86Rb+ uptake through the Na+,K+,Cl-cotransporter and minimize extrane- ous effects on ion gradients produced by opening ofthe K+ and C1-channel (Table IV) . After a 30-min stimulation, there was no detectable effect on the initial rate of bumetanide-sensitive 86Rb+ uptake. Even though these conditions are suboptimal for uptake via the K+ channels (15) there was a small but significant increase in the bumetanide-insensitive 86Rb+ uptake which can probably be attributed to 86Rb+ uptake through the K+ channels. After a 60-min stimulation with ST., there was a small 16% decrease in bumetanide-sensitive 86Rb+ uptake. This decrease can probably be attributed to a loss in cell volume due to the efflux ofcellular K+ and Cl-through the K+ and Cl-channels (15, 16) . This data agrees with the effect of STa on 86Rb+ efflux from ouabain-treated preloaded cells (Fig.  5) . Together, these data strongly suggest that STa does not directly affect the activity of the Na+,K+,Cl-cotransporter in T& cells. The data do not address a probably indirect activation of the cotransporter through changes in intracellular ion concentrations.
The effect ofSTa on secondary messengers. To further explore the mechanism of action of STa, we measured the effect ofthe enterotoxin on cellular cAMP, cGMP, and free cytosolic Ca2+ ([Ca2+]j) in the presence and absence ofVIP or carbachol.
The results are summarized in Table V . STa and carbachol had no effect on cellular cAMP, while VIP increased cAMP. This increase in cAMP by VIP was not altered by ST.. In contrast, ST. increased cellular cGMP while VIP and carbachol had no effect. The increase in cGMP by STa was not altered by either VIP or carbachol. The time course and graded dose effect of cGMP production and the increase in I8C in response to ST. are shown in Fig. 7 Because the occluding junction structure of this model epithelium has a very high resistance (8), we believe that the increased bidirectional C1-fluxes across T84 monolayers largely result from an increased transcellular movement of Cl-. In other words, Cl-flux was a result of an increase in Cl-exit through the C1-channel on the apical membrane as well as an increase in Cl-uptake by the Na+,K+,Cl-cotransport carrier across the basolateral membrane. Both pathways must be functional to allow a selective increase in transcellular C1-fluxes. Either inhibition of the Na+,K+,Cl-cotransporter by bumetanide or blockage of the Cl-channel reversed the cAMP-or cGMP-mediated mechanisms. It should be noted that blockage of the basolaterally localized K+ channel by barium also effectively inhibited net Cl-secretion. Although barium inhibited net Cl-secretion it did not reverse the increase in unidirectional Cl-fluxes induced by cyclic nucleotides as was the case with inhibition of the Cl-channel or the Na+,K+,Cl-cotransport pathway. This finding suggests that the Cl-channel and the Na',K+,Cl-cotransport pathway are regulated independently of the K+ channel.
The STa-mediated effect on C1-transport, although closely resembling the cAMP-mediated mechanism, differed in at least two respects. The time interval required to observe maximal effects of STa on either net Cl-secretion or 36C1 uptake through opening of the Cl-channels, was longer than that observed with effectors acting through cAMP. Since there was a correlation between the rise in IC and the increase in cGMP, this result implies that the intracellular mechanisms by which STa activates guanylate cyclase are slower than the mechanisms coupling VIP or PGE, receptors to adenylate cyclase. The maximal effect of STa (1O-6 M) on either net Cl-secretion or 36C1-uptake through the Cl-channels was less than that maximally produced by VIP (IO-8 M) . This result implies that cGMP may be less effective than cAMP in activating the protein kinase(s) responsible for opening the Cl-channel. Alternately, it could be argued that cGMP and cAMP open different sets of Cl-channels. The finding that the combined I,, effect of cGMP and cAMP (STa plus VIP) approximated that induced by cAMP (VIP) alone argues against the latter proposal.
The opening of K+ efflux pathway on the basolateral membrane by STa has been demonstrated in this study. This process can be blocked by Ba2+, a K+ channel blocker, but is not sensitive to inhibition by tetraethylammonium chloride, 4-aminopyridine, or apamin. Quinidine, which may release Ca2l from an intracellular store, increased the I,, before exerting an inhibitory action. The sensitivity pattern of this K+ effilux pathway, including the graded dose effect of barium inhibition, resembles that of a cAMP-sensitive pathway reported earlier for VIP and PGE, (1 1, 15) but differs from that of a Ca2"-mediated mechanism reported for carbachol (13) .
We have also shown that K+ efflux induced by STa is not additive to that induced by VIP but is additive to that induced by carbachol. Taken together these findings suggest that the same K+ channel is activated by both cAMP and cGMP. The critical involvement of this K+ efflux pathway in the Cl-secretory process is demonstrated by the fact that blockage of this pathway inhibited net Cl-secretion. The depolarization of the cell, caused by the efflux of K+, may be a necessary feature required to drive Cl-exit across the apical membrane (10) .
Recently, inhibition or stimulation of the Na+,K+,Cl-cotransport mechanism by atrial natriuretic factor (ANF) and 8-Br-cGMP but not cAMP has been suggested by other investigators (31-33), thus leading us to investigate this pathway. When Cl-secretion across the T84 monolayer increased, an increased activity of this cotransport pathway can be assumed as it is the Cl-uptake pathway. We were unable to demonstrate that STa caused any direct changes in bumetanide-sensitive 86Rb+ efflux or bumetanide-sensitive 36C1-uptake in the presence of ouabain. Concurrently, we were able to demonstrate an increase in bumetanide-insensitive 86Rb+ efflux and bumetanide-insensitive 86Rb+ uptake as well as an increase in cellular cGMP by STa. The results suggest that the Na+,K+,Clcotransport mechanism is not directly activated by STa. The presumed increase in its activity requires an active Na+,K+ ATPase pump and is probably secondary to the favorable gradient created by K+ and Cl-exits, primary regulatory processes activated by STa.
Our studies suggest that STa-induced Cl-secretion is mediated by cGMP. Its mechanism of action resembles that of cAMP (VIP and PGE1) despite the different localization of their receptor-cyclase activation. 
